Dr. Matt Kalaycio’s top 10 hematologic oncology abstracts for ASCO 2016May 27, 2016CLLFollicular Lymphoma
Low transformation rate in nodular lymphocyte–predominant Hodgkin lymphomaApril 28, 2016Follicular Lymphoma
CUDC-907 enters phase II for relapsed or refractory lymphoma and multiple myelomaApril 12, 2016Follicular Lymphoma